RaySearch Laboratories AB logo

RaySearch Laboratories AB - Class B

OTCPK:RSLBF (Sweden)   Class B
$ 8.33 -0.97 (-10.43%) 11:08 PM EST
49.77
P/B:
5.52
Market Cap:
$ 373.50M
Enterprise V:
$ 390.59M
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Avg Vol (2M):
-
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for RaySearch Laboratories AB ( ) from 2011 to May 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. RaySearch Laboratories AB stock (RSLBF) PE ratio as of May 06 2024 is 49.77. More Details

RaySearch Laboratories AB (RSLBF) PE Ratio (TTM) Chart

To

RaySearch Laboratories AB (RSLBF) PE Ratio (TTM) Historical Data

Total 1220
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
RaySearch Laboratories AB PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-06 36.9 2024-03-01 36.9
2024-05-03 36.9 2024-02-29 36.9
2024-05-02 36.9 2024-02-28 36.9
2024-05-01 36.9 2024-02-27 36.9
2024-04-30 36.9 2024-02-26 36.9
2024-04-29 36.9 2024-02-23 36.9
2024-04-26 36.9 2024-02-22 36.9
2024-04-25 36.9 2024-02-21 36.9
2024-04-24 36.9 2024-02-20 36.9
2024-04-23 36.9 2024-02-16 36.9
2024-04-22 36.9 2024-02-15 36.9
2024-04-19 36.9 2024-02-14 36.9
2024-04-18 36.9 2024-02-13 36.9
2024-04-17 36.9 2024-02-12 36.9
2024-04-16 36.9 2024-02-09 36.9
2024-04-15 36.9 2024-02-08 36.9
2024-04-12 36.9 2024-02-07 36.9
2024-04-11 36.9 2024-02-06 36.9
2024-04-10 36.9 2024-02-05 36.9
2024-04-09 36.9 2024-02-02 36.9
2024-04-08 36.9 2024-02-01 36.9
2024-04-05 36.9 2024-01-31 36.9
2024-04-04 36.9 2024-01-30 36.9
2024-04-03 36.9 2024-01-29 36.9
2024-04-02 36.9 2024-01-26 36.9
2024-04-01 36.9 2024-01-25 36.9
2024-03-28 36.9 2024-01-24 36.9
2024-03-27 36.9 2024-01-23 36.9
2024-03-26 36.9 2024-01-22 36.9
2024-03-25 36.9 2024-01-19 36.9
2024-03-22 36.9 2024-01-18 36.9
2024-03-21 36.9 2024-01-17 36.9
2024-03-20 36.9 2024-01-16 36.9
2024-03-19 36.9 2024-01-12 36.9
2024-03-18 36.9 2024-01-11 36.9
2024-03-15 36.9 2024-01-10 36.9
2024-03-14 36.9 2024-01-09 36.9
2024-03-13 36.9 2024-01-08 36.9
2024-03-12 36.9 2024-01-05 36.9
2024-03-11 36.9 2024-01-04 41.1
2024-03-08 36.9 2024-01-03 41.1
2024-03-07 36.9 2024-01-02 41.1
2024-03-06 36.9 2023-12-29 41.1
2024-03-05 36.9 2023-12-28 41.1
2024-03-04 36.9 2023-12-27 52.8

RaySearch Laboratories AB (RSLBF) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.